A Study of an Oral Entry Inhibitor, SP01A, in Treatment-Experienced HIV-Infected Patients

NCT00113412 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
32
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Samaritan Pharmaceuticals, Inc